Ani Pharmaceuticals ANIP
NASDAQ ANIP
$67.79 +0.38 (+0.56%)
At close: Nov 9, 2026 · 4:00 PM EST

Ani Pharmaceuticals (ANIP) Interest Expenses (2010 - 2013)

Updated

Analysis

Ani Pharmaceuticals (ANIP) Interest Expenses (2010 - 2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 217.00 Mn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -477.00 Mn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 269.00 Mn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Ani Pharmaceuticals 1.43 Bn 212.92 Mn 165.89 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 98.00
Jun 30, 2013 374,476.00
Mar 31, 2013 93,000.00
Dec 31, 2012 87,863.00
Sep 30, 2012 81,225.00
Jun 30, 2012 501,002.00
Mar 31, 2012 124,196.00
Dec 31, 2011 165,573.00
Sep 30, 2011 172,000.00
Jun 30, 2011 172,000.00
Mar 31, 2011 172,000.00
Dec 31, 2010 172,000.00
Sep 30, 2010 172,000.00
Jun 30, 2010 172,083.00
API Access

Ani Pharmaceuticals Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=ANIP&period=max&api_key=YOUR_API_KEY